ALEC - Alector, Inc.
2.16
0.110 5.093%
Share volume: 437,289
Last Updated: 05-12-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
0.21%
PREVIOUS CLOSE
CHG
CHG%
$2.05
0.11
0.05%
View ratios
| Fiscal Date | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | 03-31-2026 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | |
| Report Date | 08-07-2024 | 11-06-2024 | 02-26-2025 | 05-08-2025 | 08-07-2025 | 11-06-2025 | 02-25-2026 | 05-07-2026 | |
| Total revenue | 15.083 M | 15.342 M | 54.240 M | 3.674 M | 7.874 M | 3.260 M | 6.237 M | 1.046 M | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 15.083 M | 15.342 M | 54.240 M | 3.674 M | 7.874 M | 3.260 M | 6.237 M | 1.046 M | |
| 1.72% | 253.54% | -93.23% | 114.32% | -58.60% | 91.32% | -83.23% | |||
| Operating expenses | 60.689 M | 63.776 M | 61.489 M | 48.369 M | 42.012 M | 40.868 M | 45.803 M | 25.965 M | |
| Selling general and admin | 14.375 M | 15.778 M | 15.028 M | 14.728 M | 14.401 M | 11.518 M | 13.340 M | 8.108 M | |
| Research and development | 46.314 M | 47.998 M | 46.461 M | 33.641 M | 27.611 M | 29.350 M | 32.463 M | 17.857 M | |
| Total expenses | 60.689 M | 63.776 M | 61.489 M | 48.369 M | 42.012 M | 40.868 M | 45.803 M | 25.965 M | |
| 5.09% | -3.59% | -21.34% | -13.14% | -2.72% | 12.08% | -43.31% | |||
| Operating income | -45.606 M | -48.434 M | -7.249 M | -44.695 M | -34.138 M | -37.608 M | -39.566 M | -24.919 M | |
| Ebit | -38.603 M | -42.220 M | -2.026 M | -40.471 M | -30.524 M | -34.667 M | -37.099 M | -22.930 M | |
| Pretax income | -38.603 M | -42.220 M | -2.026 M | -40.471 M | -30.524 M | -34.667 M | -37.099 M | -22.930 M | |
| 9.37% | -95.20% | 1,897.58% | -24.58% | 13.57% | 7.02% | -38.19% | |||
| Income tax | 73.000 K | 0.000 | 48.000 K | 0.000 | 0.000 | 0.000 | 168.000 K | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -38.676 M | -42.220 M | -2.074 M | -40.471 M | -30.524 M | -34.667 M | -37.267 M | -22.930 M | |
| -9.16% | 95.09% | -1,851.35% | 24.58% | -13.57% | -7.50% | 38.47% |